相似文献
1
Antibody-mediated rejection across solid organ transplants: manifestations, mechanisms, and therapies.
J Clin Invest. 2017 Jun 30;127(7):2492-2504. doi: 10.1172/JCI90597. Epub 2017 Jun 12.
2
3
4
Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Hum Immunol. 2009 Aug;70(8):589-94. doi: 10.1016/j.humimm.2009.04.018. Epub 2009 Apr 15.
5
Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Hum Immunol. 2011 Jan;72(1):5-10. doi: 10.1016/j.humimm.2010.10.013. Epub 2010 Nov 10.
6
Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Transpl Immunol. 2013 Dec;29(1-4):22-7. doi: 10.1016/j.trim.2013.09.008. Epub 2013 Sep 30.
7
Antibody-mediated rejection after intestinal transplantation.
Curr Opin Organ Transplant. 2012 Jun;17(3):250-7. doi: 10.1097/MOT.0b013e3283533847.
8
Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Cardiol Young. 2011 Dec;21 Suppl 2:124-32. doi: 10.1017/S1047951111001703.
9
Graft Immunocomplex Capture Fluorescence Analysis to Detect Donor-Specific Antibodies and HLA Antigen Complexes in the Allograft.
Immunol Invest. 2017 Apr;46(3):295-304. doi: 10.1080/08820139.2016.1258711. Epub 2017 Feb 2.
10
Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
World J Gastroenterol. 2015 Oct 21;21(39):11016-26. doi: 10.3748/wjg.v21.i39.11016.
引用本文的文献
1
Acoustofluidic system for targeted antibody removal in transplantation: Enabling small-volume therapeutic apheresis.
Sci Adv. 2025 Sep 5;11(36):eady3262. doi: 10.1126/sciadv.ady3262.
2
IL-6/IL-6R Signaling Blockade Alleviates Chronic Allograft Rejection by Modulating Germinal Center B Cells and Allograft Inflammation in Murine Cardiac Transplantation.
J Inflamm Res. 2025 Jul 12;18:9145-9158. doi: 10.2147/JIR.S520034. eCollection 2025.
3
Hepatic allograft rejection after liver transplantation: Clinicopathological debates!
ILIVER. 2023 May 23;2(2):116-121. doi: 10.1016/j.iliver.2023.05.003. eCollection 2023 Jun.
4
Transplants foster B cell alloimmunity by relaying extracellular vesicles to follicular dendritic cells.
Cell Rep. 2025 Jun 24;44(6):115832. doi: 10.1016/j.celrep.2025.115832. Epub 2025 Jun 12.
5
Macrophage regulated cell death: implications and mechanisms in organ transplantation.
Front Immunol. 2025 May 23;16:1604429. doi: 10.3389/fimmu.2025.1604429. eCollection 2025.
6
Cross-organ hierarchy of HLA molecular mismatches in donor-specific antibody development in solid organ transplantations.
Cell Rep Med. 2025 Jun 17;6(6):102153. doi: 10.1016/j.xcrm.2025.102153. Epub 2025 May 30.
7
Chronic rejection models for vascularized composite tissue allotransplantation.
Sci Rep. 2025 May 15;15(1):16882. doi: 10.1038/s41598-025-01803-8.
8
CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance.
JCI Insight. 2025 Apr 8;10(7):e188624. doi: 10.1172/jci.insight.188624.
9
Lung rehabilitation using xenogeneic cross-circulation does not lead to hyperacute rejection in a human lung transplantation model.
J Heart Lung Transplant. 2025 Jul;44(7):1122-1134. doi: 10.1016/j.healun.2025.02.1696. Epub 2025 Mar 20.
10
New Paradigms in Rejection Monitoring: Lymphocyte Subsets as Noninvasive Graft Markers in Vascularized Composite Allotransplantation.
Plast Reconstr Surg Glob Open. 2025 Mar 6;13(3):e6598. doi: 10.1097/GOX.0000000000006598. eCollection 2025 Mar.
本文引用的文献
1
Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung Allografts.
Transplantation. 2017 May;101(5):e156-e165. doi: 10.1097/TP.0000000000001665.
2
Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.
Am J Transplant. 2017 Sep;17(9):2381-2389. doi: 10.1111/ajt.14228. Epub 2017 Mar 10.
3
Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies.
Hum Immunol. 2017 Apr;78(4):336-341. doi: 10.1016/j.humimm.2017.02.003. Epub 2017 Feb 9.
4
Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
Circulation. 2017 Mar 7;135(10):917-935. doi: 10.1161/CIRCULATIONAHA.116.022907. Epub 2017 Feb 1.
5
Long-term Outcomes of Kidney Transplantation in Patients With High Levels of Preformed DSA: The Necker High-Risk Transplant Program.
Transplantation. 2017 Oct;101(10):2440-2448. doi: 10.1097/TP.0000000000001650.
6
Acute antibody-mediated rejection after intestinal transplantation.
World J Transplant. 2016 Dec 24;6(4):719-728. doi: 10.5500/wjt.v6.i4.719.
7
OPTN/SRTR 2015 Annual Data Report: Kidney.
Am J Transplant. 2017 Jan;17 Suppl 1(Suppl 1):21-116. doi: 10.1111/ajt.14124.
8
Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?
Hum Immunol. 2017 Feb;78(2):64-71. doi: 10.1016/j.humimm.2016.12.005. Epub 2016 Dec 18.
9
The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss.
Am J Transplant. 2017 Jun;17(6):1574-1584. doi: 10.1111/ajt.14161. Epub 2017 Jan 25.
10
A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
Transplantation. 2017 Jun;101(6):1215-1221. doi: 10.1097/TP.0000000000001389.
Zotero 插件